Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Materialise ( (MTLS) ).
Materialise reported higher fourth-quarter 2025 revenue of 70.2 million euros, up 6.8% year on year, driven by a 16.3% surge in its Medical segment that offset declines in Software and Manufacturing. Fourth-quarter gross margin improved, operating income swung to a profit, adjusted EBITDA more than doubled, and net profit rose to 6.2 million euros, while the company absorbed non-recurring costs tied to a recent Euronext listing.
For full year 2025, revenue was broadly flat at 267.6 million euros as strong 15.4% growth in Medical was offset by weaker Software and a double-digit decline in Manufacturing, but margins edged higher and adjusted EBITDA and adjusted EBIT improved. Net profit for 2025 fell to 7.7 million euros from 13.4 million euros due mainly to adverse exchange rate effects, even as free cash flow remained positive and the net cash position and shareholders’ equity increased, underscoring a solid balance sheet but continued pressure in the manufacturing business.
The most recent analyst rating on (MTLS) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Materialise stock, see the MTLS Stock Forecast page.
Spark’s Take on MTLS Stock
According to Spark, TipRanks’ AI Analyst, MTLS is a Neutral.
The score is driven primarily by solid financial quality indicators (strong gross margin, sharply improved free cash flow, and reduced leverage), supported by an above-moving-averages price trend. These positives are tempered by pressured profitability (lower net margin/ROE), mixed momentum signals (slightly negative MACD), expensive valuation (P/E 74.28), and earnings-call risks tied to weakness and losses in the Software/Manufacturing segments despite strong Medical performance and maintained guidance.
To see Spark’s full report on MTLS stock, click here.
More about Materialise
Materialise NV is a Belgium-based provider of 3D printing and additive manufacturing solutions, operating through three main segments: Materialise Medical, Software and Manufacturing. The company focuses on medical applications, industrial manufacturing services and 3D printing software, serving healthcare providers and industrial customers globally with digital manufacturing and planning tools.
Average Trading Volume: 140,537
Technical Sentiment Signal: Strong Sell
Current Market Cap: $318.4M
See more data about MTLS stock on TipRanks’ Stock Analysis page.